Roche, Spark Extend Deadline For $4.8B Takeover Offer
Spark Therapeutics and Switzerland-based Roche have extended a deadline for Roche's $4.8 billion offer to take over the Philadelphia-based gene therapy company to give the pair more time to clear the...To view the full article, register now.
Already a subscriber? Click here to view full article